GlassScriptPhysician profile
James G Underhill
NPI 1275859498
$677.37
in general payments reported to CMS, 2019-2025
16 companies · $23.68 in 2025
The $23.68 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $19.50 · 2021: $12.33 · 2022: $106 · 2023: $257 · 2024: $48.96 · 2025: $23.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $249.33 | 2022-2023 | Intellis Adaptivestim |
| Amgen INC. | $117.46 | 2019 | |
| Lilly USA, LLC | $51.42 | 2023-2024 | Mounjaro, Zepbound |
| Organogenesis INC. | $38.48 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.94 | 2022 | |
| Wound Management Technologies, INC | $27.35 | 2019 | |
| Kci USA, INC. | $26.14 | 2019-2022 | |
| Integra Lifesciences Corporation | $23.68 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $20.70 | 2022 | |
| Daiichi Sankyo INC. | $18.59 | 2024 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $15.94 | 2022 | |
| Biocomposites INC | $13.45 | 2022 | |
| Horizon Therapeutics Plc | $13.17 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.33 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.66 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $9.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Underhill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.